Literature DB >> 9800975

C-erbB-2 protein expression in oesophageal squamous epithelium from oesophageal squamous cell carcinomas, with special reference to histological grade of carcinoma and pre-invasive lesions.

K Y Lam1, L Tin, L Ma.   

Abstract

AIMS: C-erbB-2, an oncogene, is member of the growth factor receptor family. Its role in activation of oesophageal squamous cell carcinoma is poorly understood. The aim of this study was to evaluate the part played by c-erbB-2 in oesophageal squamous cell carcinoma in Hong Kong Chinese patients.
METHODS: We examined the expression of the c-erbB-2 oncoprotein in 104 oesophageal squamous cell carcinomas from 89 men and 15 women, ranging in age from 41 to 89 years (mean 63). C-ercB-2 expression was studied with monoclonal antibody, using an antigen retrieval method.
RESULTS: Focal c-erbB-2 membrane staining was present in 10 (10%) of 104 squamous cell carcinomas. Staining was also noted in the adjacent dysplastic epithelium (n=2) and non-tumour inflamed epithelium (n=2). In carcinomas, the c-erbB-2 membrane staining was identified only in superficial well-differentiated tumour cells and the expression did not predict biological behaviour.
CONCLUSIONS: We conclude that the c-erbB-2 oncoprotein is expressed in a portion of oesophageal squamous cell carcinomas and precursor lesions. This suggests that c-erbB-2 activation plays a certain role, mostly probably during the early stages, in carcinogenesis in oesophageal squamous cell carcinomas from Hong Kong Chinese patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9800975     DOI: 10.1016/s0748-7983(98)92403-9

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  5 in total

1.  Analysis of HER2 gene amplification and protein expression in esophageal squamous cell carcinoma.

Authors:  Na Zhan; Wei-Guo Dong; Yong-Fei Tang; Ze-Sheng Wang; Cheng-Long Xiong
Journal:  Med Oncol       Date:  2011-02-13       Impact factor: 3.064

2.  Frequencies of HER-2/neu expression and gene amplification in patients with oesophageal squamous cell carcinoma.

Authors:  K Mimura; K Kono; M Hanawa; F Mitsui; H Sugai; N Miyagawa; A Ooi; H Fujii
Journal:  Br J Cancer       Date:  2005-04-11       Impact factor: 7.640

3.  Involvement of CXCR4 chemokine receptor in metastastic HER2-positive esophageal cancer.

Authors:  Stephanie J Gros; Nina Kurschat; Astrid Drenckhan; Thorsten Dohrmann; Evelyn Forberich; Katharina Effenberger; Uta Reichelt; Robert M Hoffman; Klaus Pantel; Jussuf T Kaifi; Jakob R Izbicki
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

4.  Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin.

Authors:  X Wu; A Wanders; P Wardega; B Tinge; L Gedda; S Bergstrom; L Sooman; J Gullbo; M Bergqvist; P Hesselius; J Lennartsson; S Ekman
Journal:  Br J Cancer       Date:  2009-01-13       Impact factor: 7.640

5.  Evaluation of gene amplification and protein expression of HER-2/neu in esophageal squamous cell carcinoma using Fluorescence in situ Hybridization (FISH) and immunohistochemistry.

Authors:  Yukie Sato-Kuwabara; José I Neves; José H T G Fregnani; Rubens A Sallum; Fernando A Soares
Journal:  BMC Cancer       Date:  2009-01-07       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.